Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

Abroad (travel likely)Recruiting

Conditions

Monoclonal Gammopathy of Undetermined Significance (MGUS) · Intestinal Flora · Multiple Myeloma · M-Protein

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhujiang Hospital of Southern Medical University, Guanzhou, Guangdong, China
Contact: Study coordinator (Hongwei Zhou, Professor) · hzhou@smu.edu.cn · 186 8848 9622

Study leads

Hongwei Zhou, Professor
Study Chair
Southern Medical University, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Multiple Myeloma · MGUS · Gut Microbiota

Abroad (travel likely)Recruiting

Guanzhou, China

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Multiple Myeloma · Multiple Myeloma Progression · Monoclonal Gammopathy of Undetermined Significance (MGUS)

Abroad (travel likely)Recruiting

Charlotte, United States

Pre-malignant States to Hematologic Malignancies in Firefighters

Clonal Hematopoiesis of Indeterminate Potential · Monoclonal Gammopathy · Non Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Charlotte, United States

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance (MGUS) · Smoldering Multiple Myeloma (SMM)

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States · Boston, United States